Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Regenerative Medicine | 10 | 2025 | 303 | 3.620 |
Why?
|
Muscle, Skeletal | 30 | 2024 | 4959 | 2.940 |
Why?
|
Rehabilitation | 4 | 2020 | 128 | 1.800 |
Why?
|
Extracellular Matrix | 9 | 2025 | 1727 | 1.510 |
Why?
|
Osteoarthritis, Knee | 6 | 2025 | 1248 | 1.510 |
Why?
|
Osteoarthritis | 3 | 2025 | 1051 | 1.490 |
Why?
|
Myoblasts | 8 | 2020 | 234 | 1.420 |
Why?
|
Glucuronidase | 3 | 2021 | 205 | 1.380 |
Why?
|
Aging | 13 | 2024 | 8723 | 1.370 |
Why?
|
Stem Cells | 11 | 2024 | 3537 | 1.240 |
Why?
|
Regeneration | 16 | 2023 | 1516 | 1.180 |
Why?
|
Menopause | 2 | 2025 | 1659 | 1.030 |
Why?
|
Arsenic | 6 | 2023 | 357 | 0.980 |
Why?
|
Muscle Development | 7 | 2020 | 258 | 0.960 |
Why?
|
Complement C4b | 1 | 2023 | 124 | 0.820 |
Why?
|
Physical Conditioning, Animal | 3 | 2017 | 365 | 0.800 |
Why?
|
Muscular Dystrophy, Animal | 3 | 2013 | 89 | 0.800 |
Why?
|
Satellite Cells, Skeletal Muscle | 2 | 2016 | 124 | 0.760 |
Why?
|
Cartilage Diseases | 1 | 2023 | 159 | 0.730 |
Why?
|
Stem Cell Transplantation | 5 | 2021 | 1600 | 0.710 |
Why?
|
Progesterone | 1 | 2025 | 751 | 0.700 |
Why?
|
Musculoskeletal Diseases | 3 | 2017 | 598 | 0.680 |
Why?
|
Platelet-Rich Plasma | 1 | 2022 | 180 | 0.680 |
Why?
|
Cartilage, Articular | 2 | 2025 | 1088 | 0.640 |
Why?
|
Guided Tissue Regeneration | 2 | 2016 | 86 | 0.610 |
Why?
|
Cues | 1 | 2023 | 877 | 0.610 |
Why?
|
Muscle Contraction | 5 | 2023 | 1207 | 0.580 |
Why?
|
Estradiol | 1 | 2025 | 1947 | 0.570 |
Why?
|
Mice, Inbred C57BL | 13 | 2025 | 22341 | 0.560 |
Why?
|
Muscular Diseases | 3 | 2023 | 551 | 0.550 |
Why?
|
Resistance Training | 3 | 2024 | 197 | 0.540 |
Why?
|
Biophysics | 1 | 2018 | 375 | 0.540 |
Why?
|
Electric Stimulation Therapy | 2 | 2013 | 635 | 0.530 |
Why?
|
Muscle Fibers, Skeletal | 5 | 2023 | 552 | 0.520 |
Why?
|
Sarcopenia | 1 | 2021 | 378 | 0.510 |
Why?
|
Exercise | 6 | 2024 | 5939 | 0.500 |
Why?
|
Spinal Cord Injuries | 4 | 2013 | 929 | 0.490 |
Why?
|
Periodicals as Topic | 2 | 2024 | 1463 | 0.490 |
Why?
|
Tissue Scaffolds | 4 | 2016 | 934 | 0.480 |
Why?
|
Wheelchairs | 2 | 2005 | 78 | 0.470 |
Why?
|
Neural Conduction | 1 | 2015 | 442 | 0.450 |
Why?
|
Fibroblasts | 4 | 2021 | 4162 | 0.450 |
Why?
|
Chondrocytes | 3 | 2025 | 798 | 0.450 |
Why?
|
Animals | 43 | 2025 | 168800 | 0.440 |
Why?
|
Myofibrils | 1 | 2014 | 143 | 0.440 |
Why?
|
Models, Animal | 3 | 2017 | 2120 | 0.430 |
Why?
|
DNA, Mitochondrial | 1 | 2018 | 870 | 0.420 |
Why?
|
Professional Role | 1 | 2016 | 314 | 0.420 |
Why?
|
Neuromuscular Junction | 2 | 2013 | 399 | 0.420 |
Why?
|
Myoblasts, Skeletal | 1 | 2013 | 74 | 0.410 |
Why?
|
Collagen Type II | 2 | 2023 | 151 | 0.400 |
Why?
|
Mitochondria | 4 | 2020 | 3672 | 0.380 |
Why?
|
Longevity | 1 | 2019 | 1085 | 0.370 |
Why?
|
Mice | 28 | 2025 | 81839 | 0.370 |
Why?
|
Military Medicine | 1 | 2013 | 185 | 0.360 |
Why?
|
Electromyography | 1 | 2015 | 1398 | 0.350 |
Why?
|
Receptors, Cell Surface | 1 | 2018 | 2815 | 0.320 |
Why?
|
Muscle Strength | 4 | 2021 | 638 | 0.320 |
Why?
|
Cell Differentiation | 11 | 2024 | 11642 | 0.310 |
Why?
|
Exercise Therapy | 2 | 2014 | 938 | 0.300 |
Why?
|
Dystrophin | 1 | 2009 | 283 | 0.290 |
Why?
|
Exosomes | 2 | 2022 | 417 | 0.280 |
Why?
|
Energy Metabolism | 2 | 2018 | 2894 | 0.280 |
Why?
|
NF-kappa B | 1 | 2016 | 2495 | 0.280 |
Why?
|
Wound Healing | 4 | 2017 | 2795 | 0.270 |
Why?
|
Nervous System Diseases | 1 | 2017 | 1657 | 0.270 |
Why?
|
Self-Help Devices | 1 | 2007 | 62 | 0.260 |
Why?
|
Electric Stimulation | 2 | 2023 | 1736 | 0.250 |
Why?
|
Physical Therapy Modalities | 3 | 2021 | 533 | 0.240 |
Why?
|
Isometric Contraction | 1 | 2005 | 149 | 0.230 |
Why?
|
Paraplegia | 1 | 2005 | 159 | 0.230 |
Why?
|
Military Personnel | 3 | 2022 | 1260 | 0.220 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2024 | 195 | 0.220 |
Why?
|
Muscular Dystrophy, Duchenne | 3 | 2011 | 271 | 0.200 |
Why?
|
Autophagy | 3 | 2022 | 1349 | 0.200 |
Why?
|
Epigenesis, Genetic | 3 | 2023 | 3818 | 0.200 |
Why?
|
Disease Models, Animal | 4 | 2025 | 18321 | 0.200 |
Why?
|
Humans | 42 | 2025 | 766117 | 0.190 |
Why?
|
Neural Stem Cells | 2 | 2021 | 897 | 0.190 |
Why?
|
Arm | 1 | 2005 | 590 | 0.190 |
Why?
|
United States Department of Veterans Affairs | 1 | 2007 | 937 | 0.190 |
Why?
|
Injections, Intra-Articular | 1 | 2022 | 279 | 0.190 |
Why?
|
Caspases, Initiator | 1 | 2020 | 31 | 0.180 |
Why?
|
Cicatrix, Hypertrophic | 1 | 2021 | 80 | 0.180 |
Why?
|
Mechanotransduction, Cellular | 2 | 2018 | 539 | 0.170 |
Why?
|
Contusions | 2 | 2012 | 78 | 0.170 |
Why?
|
Male | 26 | 2025 | 363935 | 0.170 |
Why?
|
Genomics | 1 | 2016 | 5926 | 0.170 |
Why?
|
Cells, Cultured | 5 | 2024 | 18967 | 0.160 |
Why?
|
Caspase 1 | 1 | 2020 | 227 | 0.160 |
Why?
|
Knee Injuries | 1 | 2024 | 495 | 0.160 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2022 | 1935 | 0.160 |
Why?
|
Cartilage | 1 | 2023 | 797 | 0.160 |
Why?
|
Contracture | 1 | 2021 | 235 | 0.160 |
Why?
|
Chloroquine | 1 | 2020 | 276 | 0.160 |
Why?
|
Vesicle-Associated Membrane Protein 3 | 3 | 2022 | 12 | 0.150 |
Why?
|
MicroRNAs | 2 | 2024 | 3787 | 0.150 |
Why?
|
Torsion, Mechanical | 1 | 2017 | 15 | 0.140 |
Why?
|
Recovery of Function | 2 | 2021 | 2971 | 0.140 |
Why?
|
Mammals | 1 | 2023 | 1126 | 0.140 |
Why?
|
Forelimb | 1 | 2017 | 116 | 0.140 |
Why?
|
Prescriptions | 2 | 2011 | 388 | 0.130 |
Why?
|
Peripheral Nervous System | 1 | 2017 | 151 | 0.130 |
Why?
|
Certification | 1 | 2020 | 420 | 0.130 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2018 | 3606 | 0.130 |
Why?
|
Estrogens | 1 | 2023 | 1528 | 0.130 |
Why?
|
Dependovirus | 1 | 2021 | 721 | 0.130 |
Why?
|
Signal Transduction | 6 | 2024 | 23605 | 0.120 |
Why?
|
Acyltransferases | 1 | 2017 | 305 | 0.120 |
Why?
|
Congresses as Topic | 1 | 2020 | 811 | 0.120 |
Why?
|
Transcription Factor RelA | 1 | 2016 | 252 | 0.120 |
Why?
|
Torque | 2 | 2005 | 132 | 0.120 |
Why?
|
Female | 19 | 2025 | 396233 | 0.110 |
Why?
|
Athletic Injuries | 1 | 2024 | 1244 | 0.110 |
Why?
|
Resilience, Psychological | 1 | 2022 | 808 | 0.110 |
Why?
|
Myostatin | 3 | 2012 | 129 | 0.110 |
Why?
|
Mitochondria, Muscle | 1 | 2014 | 170 | 0.110 |
Why?
|
Quadriceps Muscle | 1 | 2014 | 156 | 0.110 |
Why?
|
Fibrosis | 3 | 2017 | 2073 | 0.110 |
Why?
|
Mice, Inbred mdx | 1 | 2013 | 90 | 0.110 |
Why?
|
Bioengineering | 1 | 2013 | 97 | 0.100 |
Why?
|
Leg Injuries | 1 | 2014 | 180 | 0.100 |
Why?
|
Veterans | 1 | 2007 | 2667 | 0.100 |
Why?
|
Gene Expression Regulation | 3 | 2021 | 11906 | 0.100 |
Why?
|
Lipolysis | 1 | 2013 | 211 | 0.100 |
Why?
|
HEK293 Cells | 1 | 2021 | 4263 | 0.100 |
Why?
|
Multiple Sclerosis | 1 | 2007 | 3212 | 0.100 |
Why?
|
Muscular Atrophy | 1 | 2014 | 335 | 0.090 |
Why?
|
Ischemia | 1 | 2020 | 1904 | 0.090 |
Why?
|
Central Nervous System Diseases | 1 | 2016 | 519 | 0.090 |
Why?
|
Genetic Vectors | 1 | 2021 | 3400 | 0.090 |
Why?
|
Artificial Limbs | 1 | 2013 | 121 | 0.090 |
Why?
|
Stress, Physiological | 1 | 2018 | 1405 | 0.090 |
Why?
|
Fellowships and Scholarships | 1 | 2020 | 1134 | 0.090 |
Why?
|
Losartan | 1 | 2012 | 263 | 0.090 |
Why?
|
Reactive Oxygen Species | 2 | 2020 | 2144 | 0.090 |
Why?
|
Environmental Pollutants | 1 | 2020 | 1294 | 0.090 |
Why?
|
Robotics | 1 | 2017 | 807 | 0.090 |
Why?
|
Transduction, Genetic | 2 | 2010 | 898 | 0.090 |
Why?
|
Burns | 1 | 2021 | 1904 | 0.080 |
Why?
|
Electrodes | 1 | 2012 | 610 | 0.080 |
Why?
|
Stem Cell Niche | 1 | 2013 | 347 | 0.080 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 3424 | 0.080 |
Why?
|
Suramin | 1 | 2008 | 34 | 0.080 |
Why?
|
beta-Galactosidase | 1 | 2010 | 573 | 0.080 |
Why?
|
Biomedical Research | 1 | 2024 | 3458 | 0.080 |
Why?
|
Hindlimb Suspension | 1 | 2009 | 77 | 0.080 |
Why?
|
Age Factors | 2 | 2021 | 18386 | 0.080 |
Why?
|
Action Potentials | 1 | 2015 | 1834 | 0.070 |
Why?
|
Phosphoproteins | 1 | 2017 | 2445 | 0.070 |
Why?
|
Urinary Bladder | 1 | 2014 | 1155 | 0.070 |
Why?
|
Promoter Regions, Genetic | 1 | 2018 | 5784 | 0.070 |
Why?
|
Oxidative Phosphorylation | 2 | 2020 | 502 | 0.070 |
Why?
|
Mice, SCID | 1 | 2012 | 2626 | 0.070 |
Why?
|
Cell Proliferation | 5 | 2020 | 10433 | 0.070 |
Why?
|
Parkinson Disease | 1 | 2021 | 2885 | 0.070 |
Why?
|
Mice, Knockout | 2 | 2020 | 14456 | 0.070 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2017 | 2898 | 0.070 |
Why?
|
Tissue Engineering | 1 | 2016 | 1857 | 0.070 |
Why?
|
Curriculum | 1 | 2020 | 3784 | 0.070 |
Why?
|
Brain-Derived Neurotrophic Factor | 2 | 2022 | 607 | 0.060 |
Why?
|
Stroke | 2 | 2021 | 9748 | 0.060 |
Why?
|
Diffusion of Innovation | 1 | 2010 | 723 | 0.060 |
Why?
|
Fluorescent Antibody Technique | 1 | 2010 | 2469 | 0.060 |
Why?
|
Cell Cycle Proteins | 1 | 2017 | 3436 | 0.060 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2013 | 1245 | 0.060 |
Why?
|
Central Nervous System | 1 | 2013 | 1343 | 0.060 |
Why?
|
Glycolysis | 2 | 2020 | 837 | 0.060 |
Why?
|
Aminopropionitrile | 1 | 2024 | 9 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2023 | 20137 | 0.060 |
Why?
|
DNA Methylation | 1 | 2018 | 4425 | 0.060 |
Why?
|
Proteoglycans | 1 | 2007 | 794 | 0.060 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2009 | 504 | 0.060 |
Why?
|
Oncostatin M | 1 | 2023 | 42 | 0.060 |
Why?
|
Patient Selection | 1 | 2016 | 4249 | 0.060 |
Why?
|
Shoulder Pain | 1 | 2005 | 152 | 0.050 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2007 | 637 | 0.050 |
Why?
|
Oxidative Stress | 1 | 2014 | 3140 | 0.050 |
Why?
|
Extracellular Matrix Proteins | 1 | 2007 | 833 | 0.050 |
Why?
|
Antihypertensive Agents | 1 | 2012 | 2028 | 0.050 |
Why?
|
Shoulder | 1 | 2005 | 299 | 0.050 |
Why?
|
Cell Line | 4 | 2021 | 15546 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3111 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3233 | 0.050 |
Why?
|
Kinetics | 1 | 2010 | 6273 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2016 | 3928 | 0.050 |
Why?
|
Phenotype | 2 | 2023 | 16716 | 0.050 |
Why?
|
Pregnancy | 1 | 2023 | 30233 | 0.050 |
Why?
|
Models, Biological | 1 | 2018 | 9445 | 0.050 |
Why?
|
Collagen | 1 | 2010 | 2617 | 0.050 |
Why?
|
Forecasting | 1 | 2010 | 2936 | 0.050 |
Why?
|
Adipose Tissue | 1 | 2013 | 3315 | 0.050 |
Why?
|
Adult | 8 | 2024 | 223139 | 0.050 |
Why?
|
Cell Lineage | 1 | 2010 | 2573 | 0.040 |
Why?
|
Neurosecretory Systems | 1 | 2022 | 223 | 0.040 |
Why?
|
Therapies, Investigational | 1 | 2021 | 110 | 0.040 |
Why?
|
Research | 1 | 2009 | 1975 | 0.040 |
Why?
|
Muscle Cells | 1 | 2020 | 194 | 0.040 |
Why?
|
Follistatin | 2 | 2012 | 138 | 0.040 |
Why?
|
Transforming Growth Factor beta | 1 | 2007 | 1996 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2015 | 14747 | 0.040 |
Why?
|
Environmental Exposure | 1 | 2014 | 4544 | 0.040 |
Why?
|
Evidence-Based Medicine | 1 | 2011 | 3690 | 0.040 |
Why?
|
Carbonic Anhydrases | 1 | 1999 | 107 | 0.040 |
Why?
|
Hormones | 1 | 2022 | 865 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2009 | 3501 | 0.040 |
Why?
|
Acids | 1 | 2018 | 125 | 0.040 |
Why?
|
Range of Motion, Articular | 1 | 2005 | 1593 | 0.040 |
Why?
|
Shoulder Joint | 1 | 2005 | 740 | 0.040 |
Why?
|
Cell Movement | 1 | 2010 | 5196 | 0.040 |
Why?
|
Young Adult | 4 | 2024 | 59868 | 0.040 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2018 | 292 | 0.040 |
Why?
|
Transcription Factors | 1 | 2017 | 12130 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 1 | 2024 | 36548 | 0.030 |
Why?
|
Extracellular Space | 1 | 2018 | 563 | 0.030 |
Why?
|
Interleukin-1beta | 1 | 2022 | 1028 | 0.030 |
Why?
|
Rats | 3 | 2021 | 23717 | 0.030 |
Why?
|
Microtubule-Associated Proteins | 1 | 2020 | 1068 | 0.030 |
Why?
|
Data Interpretation, Statistical | 1 | 2005 | 2689 | 0.030 |
Why?
|
Biomimetic Materials | 1 | 2016 | 170 | 0.030 |
Why?
|
Explosive Agents | 1 | 2014 | 26 | 0.030 |
Why?
|
Neurons | 1 | 2013 | 9521 | 0.030 |
Why?
|
Tensile Strength | 1 | 2014 | 332 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2024 | 2646 | 0.030 |
Why?
|
Receptor, Endothelin A | 1 | 2013 | 55 | 0.030 |
Why?
|
Cell Death | 1 | 2018 | 1676 | 0.030 |
Why?
|
Afghan Campaign 2001- | 1 | 2014 | 298 | 0.030 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2014 | 227 | 0.030 |
Why?
|
Neovascularization, Physiologic | 1 | 2020 | 1370 | 0.030 |
Why?
|
Rabbits | 1 | 2018 | 4730 | 0.020 |
Why?
|
Oxygen Consumption | 1 | 2018 | 1872 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2018 | 1310 | 0.020 |
Why?
|
Muscle Weakness | 1 | 2014 | 412 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2020 | 2455 | 0.020 |
Why?
|
Ultrasonography | 1 | 2024 | 5988 | 0.020 |
Why?
|
Injury Severity Score | 1 | 2014 | 1049 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2022 | 4342 | 0.020 |
Why?
|
Sex Factors | 1 | 2024 | 10614 | 0.020 |
Why?
|
Exercise Test | 1 | 2017 | 2185 | 0.020 |
Why?
|
Phosphorylation | 1 | 2020 | 8292 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2017 | 1885 | 0.020 |
Why?
|
Peripheral Arterial Disease | 1 | 2020 | 1306 | 0.020 |
Why?
|
Weight-Bearing | 1 | 2011 | 530 | 0.020 |
Why?
|
Equipment Design | 1 | 2016 | 3489 | 0.020 |
Why?
|
Postoperative Care | 1 | 2014 | 1475 | 0.020 |
Why?
|
Decorin | 1 | 2007 | 38 | 0.020 |
Why?
|
Motor Activity | 1 | 2017 | 2711 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2023 | 9527 | 0.020 |
Why?
|
Cytokines | 1 | 2022 | 7426 | 0.020 |
Why?
|
Injections, Intramuscular | 1 | 2008 | 551 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2005 | 22228 | 0.020 |
Why?
|
Middle Aged | 3 | 2007 | 223083 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4565 | 0.020 |
Why?
|
Cognition | 1 | 2023 | 7050 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2007 | 651 | 0.020 |
Why?
|
Preoperative Care | 1 | 2014 | 2249 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2022 | 7850 | 0.020 |
Why?
|
Hippocampus | 1 | 2017 | 3773 | 0.010 |
Why?
|
Apoptosis | 1 | 2020 | 9508 | 0.010 |
Why?
|
Swine | 1 | 2014 | 5986 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2016 | 8525 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10860 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2017 | 12775 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 3801 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2007 | 59515 | 0.010 |
Why?
|
Down-Regulation | 1 | 2008 | 2927 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2012 | 10737 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8725 | 0.010 |
Why?
|
Hexosephosphates | 1 | 1999 | 24 | 0.010 |
Why?
|
Prospective Studies | 1 | 2024 | 54812 | 0.010 |
Why?
|
United States | 1 | 2007 | 72920 | 0.010 |
Why?
|
Carbonic Anhydrase Inhibitors | 1 | 1999 | 93 | 0.010 |
Why?
|
Muscle Fatigue | 1 | 1999 | 95 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2007 | 81565 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2007 | 6493 | 0.010 |
Why?
|
Brain | 1 | 2023 | 27177 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2009 | 11035 | 0.010 |
Why?
|
Rats, Wistar | 1 | 1999 | 1886 | 0.010 |
Why?
|
Aged | 1 | 2007 | 171219 | 0.010 |
Why?
|
Adolescent | 1 | 2022 | 88819 | 0.010 |
Why?
|
Animals, Newborn | 1 | 1999 | 2677 | 0.010 |
Why?
|
Risk Assessment | 1 | 2014 | 24276 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2014 | 39243 | 0.010 |
Why?
|
Time Factors | 1 | 2012 | 40108 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2014 | 65219 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 2008 | 13635 | 0.000 |
Why?
|